FDA Drug recall D-0881-2021
ZTE-1020 Formula
- FDA Drug
- Class II
- terminated
- Published 2021-10-06
On 2021-10-06 the FDA classified a Class II recall of ZTE-1020 Formula by Washington Homeopathic Products, citing out-of-specification test results obtained for identification testing based on HPTLC analysis.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0881-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-08-20 |
| Published | 2021-10-06 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Washington Homeopathic Products |
| Distribution | US |
Product
ZTE-1020 Formula. Contents 1000ml. WHP Homeopathic Medicine, For Manufacturing Use Only, REMEDY: Aurum Metallicum 10X, Crataegus Oxyacantha 10X, Baryta Carbonica 10X, Digitalis Purpurea 10X, Zincum Muriaticum 13X, Chromium Sulphuricum 10X, Manganum Metallicum 10X, Dilution Alcohol 20%. Manufactured for Optimal Health Dimensions. RX Only, Manufactured by Washington Homeopathic Products, Inc. 260 JR Hawvermale Way, Berkeley Springs, WV, 25411.
Reason
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Identifiers
| code_info | Lot # 25740, Exp 8/17/2026 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0881-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.